![David Slack](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Slack
Algemeen Directeur bij
Cend Therapeutics, Inc.
Profiel
David Slack is currently the President, Chief Executive Officer & Director at Cend Therapeutics, Inc. He is also the Chairman at Lisata Therapeutics Australia Pty Ltd. Previously, he held positions such as Director-Technology Alliances & Licensing at Aventis Pharmaceuticals, Inc. and Rhone-Poulenc Rorer Pharmaceuticals, Inc. He was also the Vice President-Business Development at Ionis Pharmaceuticals, Inc. and the Chief Business Officer at Viracta Subsidiary, Inc. Additionally, he worked as a Principal at DS Lifescience Consulting.
Mr. Slack's education includes an undergraduate degree from California State University-Sacramento and an MBA from Monterey Institute of International Studies.
Actieve functies van David Slack
| Bedrijven | Functie | Begin |
|---|---|---|
Cend Therapeutics, Inc.
 Cend Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company that provides treatment for tumor cancers | Algemeen Directeur | 08-07-2020 |
Lisata Therapeutics Australia Pty Ltd. | Voorzitter | - |
Eerdere bekende functies van David Slack
| Bedrijven | Functie | Einde |
|---|---|---|
| LISATA THERAPEUTICS, INC. | President | 01-05-2023 |
DS Lifescience Consulting | Corporate Officer/Principal | 01-03-2021 |
Viracta Subsidiary, Inc.
 Viracta Subsidiary, Inc. BiotechnologyHealth Technology Develops proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus | Corporate Officer/Principal | 01-07-2020 |
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-01-2004 |
Rhone-Poulenc Rorer Pharmaceuticals, Inc. | Corporate Officer/Principal | 01-01-2000 |
Opleiding van David Slack
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
63
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Ionis Pharmaceuticals, Inc.
 Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
California State University-Sacramento
 California State University-Sacramento Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Monterey Institute of International Studies
 Monterey Institute of International Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rhone-Poulenc Rorer Pharmaceuticals, Inc. | |
Viracta Subsidiary, Inc.
Viracta Subsidiary, Inc. BiotechnologyHealth Technology Develops proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus | Health Technology |
Cend Therapeutics, Inc.
Cend Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company that provides treatment for tumor cancers | Health Technology |
Lisata Therapeutics, Inc.
 Lisata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
Lisata Therapeutics Australia Pty Ltd. | |
DS Lifescience Consulting |
